"Complied With All Legalities": Patanjali Amid Row Over Its COVID-19 Drug

Ruben Fields
June 27, 2020

After the Centre on Tuesday asked Patanjali Ayurved Limited to stop advertising Covid-19 remedies, the company had publicly claimed it had conducted case studies in "several cities including Delhi, Ahmedabad and Meerut".

Apart from the Rajasthan government, the Uttarakhand government also plans to serve a notice to Patanjali Ayurved for launching a drug claiming to be a cure for Covid-19 when it had only applied for a licence to manufacture an immunity booster against cough and fever.

The complaint further mentioned about the press conference conducted by Baba Ramdev on June 24, during which he claimed that tablets and oil launched by Patanjali could cure the disease within 3-7 days, with 100 per cent successful results and no fatality rate.

"Ministry will have the study documents verified for validation of the data of the research outcome", the acknowledgement letter said. Such act of respondents will cost life of millions who put blind trust in "Patanjali" as a leading herbal products' manufacturer. After being examined by a panel of experts in the department, we issued the license on June 11.

"Manufacture and sale of a medicine is carried out as per the rules laid down by the government and not in accordance with someone's personal belief or ideology", it said. State Department of Medical Education and Drugs (MEDD) has given final nod for the these entities including companies to conduct research following all ICMR regulations.

Xbox Lockhart spotted in Microsoft documentation and Xbox One OS
That's less than what the current Xbox One X is capable of, and resolutions more common for popular gaming monitors than TVs. Update: The Xbox Lockhart documentation leak has drawn out some new details on what kind of hardware it may include.

Saini, however, didn't respond when reminded that the purported Covid-19 medicine - "Coronil" and "Swasari Vati" pills packed in a small carton and priced Rs 545 per 30-day dose - have already reached shops in Uttar Pradesh.

Patanjali made quite a stir when it announced a new COVID-19 drug.

State Home Minister Anil Deshmukh said, "The National Institute of Medical Sciences, Jaipur, will find out whether clinical trials of Patanjali Ayurved's "coronil" were done at all ..."

The "Coronil kit" as the medication is being called consists of 3 medicines - two in tablet form and one in liquid form. The ministry had also sought the concerned State Licensing Authority of Uttrakhand government to provide copies of license and product approval details of the said drugs.

Other reports by

Discuss This Article